Katherine Singson New CEO of Volpara Solutions

Physica System Trabecular Titanium Tibial Plate – 1st Surgery Performed by Dr. Ivan De Martino

Luigi Ferrari, LimaCorporate CEO, commented: "TT Tibial plate is an important addition to the Physica system and will enable LimaCorporate to approach a new segment of the total knee market. 

Virtual Short Course Offers New Insights for Corrosion Prevention and Sustainability of Biomedical Implants and Devices

AMPP’s Corrosion Technical Series is now offering a new 6-hour short course on corrosion prevention in metallic biomaterials and biomedical devices.

Dr. Michael Cantor Named Intuition Robotics 1st Chief Medical Officer

The company recently announced its plan to extend to healthcare.

Katherine Singson has been hired as the new CEO of Volpara Solutions.

Katherine Singson role will be to drive continued growth for Volpara’s breast cancer detection and patient tracking software. With 30+ years of experience from start-ups to multinationals including NeXT/Apple®, Pixar® and Microsoft®, Katherine brings both business-to-business as well as direct-to-consumer experience to this crucial new role.

After being mentored by Steve Jobs at all three of his companies, she spent several years abroad including in Sydney, Australia.  A highlight of this time overseas was working at Microsoft ANZ (Australia & New Zealand) where she partnered with Oprah Winfrey’s Ultimate Australian Adventure* to showcase both Windows and Xbox in a deeply humanistic manner.  Katherine is also a recent breast cancer survivor.

Volpara combines artificial intelligence, physics and data to measure breast density for early detection of cancer as well as the clinical management of images. Nearly half of women in the US have dense breast tissue.  Objective breast density analysis can help clinicians and their patients create a plan for ongoing screening based on each woman’s individual risk factors.  Additionally, Volpara’s software provides quality control for mammography centers and patient tracking software.

“As a purpose-driven technology company with the potential to transform the future of breast cancer, we’re excited to have someone of Katherine’s experience unleash our potential,” said Dr. Ralph Highnam, Founder and New Zealand-based Group CEO. “Volpara is already working with luminary customers across the US, including renowned sites in New York, Houston, San Francisco, Austin, Charlotte and Seattle, and of course, we want to reach many more. We look forward to Katherine positively impacting the healthcare industry and seeing how she’ll no doubt tap into the power and passion of women to obliterate advanced-stage breast cancer.”

“In these uncertain times, we aim to create a nimble, responsive and tastefully relentless approach to addressing this destructive disease,” said Katherine. “Since Covid-19, the idea of actively participating in one’s own self-care in partnership with leading-edge healthcare providers is stronger than ever.”

spot_img

DON'T MISS

Subscribe to Medical Device News Magazine here.

Related Articles